Investment
Features
FeesSafety
Academy
More
Pluang+

Boost Run rated Buy at $15 despite 64% drop, backed by strong contracts and scalable model.

Analyst Insights
17 Sep 2026
Seeking Alpha
View Source
Bullish
Boost Run rated Buy at $15 despite 64% drop, backed by strong contracts and scalable model.

Boost Run (BRUN) is rated Buy at around $15 after its share price fell 64%, supported by strong multi-year prepaid customer contracts that reduce capital risk. The company's business model focuses on securing contracts before hardware purchases, aligning growth with demand and improving cash returns from GPU systems. While reported gross margins appear high, true profitability depends on contract terms and execution, with risks including customer concentration and hardware obsolescence. The company aims to convert $1.9 billion in total contract value into $500–$600 million annual revenue by 2027, making it an attractive long-term investment despite current losses.

Boost Run's share price fell 64%, with a target price around $15, providing context for readers interested in this stock. For readers following the Technology sector, here is Pluang's market snapshot as of Sep 17, 2026 17:41 WIB: out of 150 priced US tech stocks, 133 rose and 14 fell today. Notable movers include CLSK at USD 13.16 (+2.89%, 79% buy orders, typical hold time 19 days), GLW at USD 148.31 (+2.83%, 71% sell orders, typical hold time 33 days), and TER at USD 350.55 (+2.76%, 93% sell orders, typical hold time 36 days).

More News

Filament to supply psilocybin capsules for Dutch clinical study on low and medium doses

Filament to supply psilocybin capsules for Dutch clinical study on low and medium doses

Rhelion Life Sciences' subsidiary Filament Health has signed an agreement to supply PEX010 psilocybin capsules and matching placebos for a clinical study by the Centre for Human Drug Research in the Netherlands. The study focuses on low and medium do...

Company Fundamentals
Bullish
4 hours ago
Moving iMage Technologies to report Q4 fiscal 2026 results on Sept 24 with investor call.

Moving iMage Technologies to report Q4 fiscal 2026 results on Sept 24 with investor call.

Moving iMage Technologies, a provider of cinema technology products, will announce its Q4 fiscal 2026 financial results before the market opens on September 24, 2026. The company will host an investor call at 11:00 am ET the same day to discuss the r...

Company Fundamentals
Neutral
4 hours ago
Eloro Resources sets up Hong Kong subsidiary to boost Asia-Pacific investor relations and concentrate sales.

Eloro Resources sets up Hong Kong subsidiary to boost Asia-Pacific investor relations and concentrate sales.

Eloro Resources Ltd. is establishing a wholly-owned subsidiary in Hong Kong called Eloro Resources (Asia) Ltd. This new entity will serve as a regional platform to support project development, concentrate sales, marketing, investor relations, and cap...

Market News
Bullish
4 hours ago
VICI Properties offers higher yield than Realty Income but with more tenant risk.

VICI Properties offers higher yield than Realty Income but with more tenant risk.

VICI Properties and Realty Income, two REITs with different portfolios, recently reported earnings highlighting a choice between higher yield and dividend stability. VICI offers a 7.19% yield with faster payout growth but has concentrated tenant risk...

Company Fundamentals
Neutral
4 hours ago
Paychex posts strong Q4 2026 growth and maintains Buy rating with 4% yield and solid FY27 outlook

Paychex posts strong Q4 2026 growth and maintains Buy rating with 4% yield and solid FY27 outlook

Paychex reported a 12% revenue increase and 11% EPS growth in Q4 2026, supported by synergies from its Paycor acquisition and organic gains. The company also expanded its margins by 70 basis points. For fiscal year 2027, Paychex projects 5-6% revenue...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App